{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:48:42Z","timestamp":1781765322475,"version":"3.54.5"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/ico.0b013e3182107c8e","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:01:48Z","timestamp":1317772908000},"page":"81-83","source":"Crossref","is-referenced-by-count":10,"title":["A Significant Drug\u2013Drug Interaction Detected Through Corneal Examination: Resolution of Cornea Verticillata While Using Amiodarone"],"prefix":"10.1097","volume":"31","author":[{"given":"Sonia","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatinee Y","family":"Bunya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Orlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Sulewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L","family":"Dunaief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9149(02)03008-4","article-title":"Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.","volume":"91","author":"Al-Khatib","year":"2003","journal-title":"Am J Cardiol"},{"key":"R2-15-20210204","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/bjo.66.10.676","article-title":"Ocular changes resulting from therapy with amiodarone.","volume":"66","author":"Ingram","year":"1982","journal-title":"Br J Ophthalmol"},{"key":"R3-15-20210204","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0161-6420(84)34165-3","article-title":"Clinical experience and grading of amiodarone keratopathy.","volume":"91","author":"Orlando","year":"1984","journal-title":"Ophthalmology"},{"key":"R4-15-20210204","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1755-3768.1987.tb08490.x","article-title":"Impairment of colour vision associated with amiodarone keratopathy.","volume":"65","author":"Duff","year":"1987","journal-title":"Acta Ophthalmol"},{"key":"R5-15-20210204","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1755-3768.1983.tb01447.x","article-title":"Amiodarone induced cornea verticillata.","volume":"61","author":"Nielsen","year":"1983","journal-title":"Acta Ophthalmol"},{"key":"R6-15-20210204","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/archopht.1983.01040020556010","article-title":"Amiodarone-induced lens opacities.","volume":"101","author":"Flach","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R7-15-20210204","first-page":"468","article-title":"Amiodarone keratopathy and lens opacities.","volume":"54","author":"Dolan","year":"1985","journal-title":"J Am Optom Assoc"},{"key":"R8-15-20210204","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0002-9394(99)00016-1","article-title":"Features of amiodarone-induced optic neuropathy.","volume":"127","author":"Macaluso","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R9-15-20210204","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archopht.1982.01030030603011","article-title":"Amiodarone keratopathy. Correlation to dosage and duration.","volume":"100","author":"Kaplan","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"R10-15-20210204","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","article-title":"Amiodarone keratopathy. Drug-induced lipid storage disease.","volume":"99","author":"DAmico","year":"1981","journal-title":"Arch Ophthalmol"},{"key":"R11-15-20210204","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archopht.1982.01030040278015","article-title":"Amodiaquine ocular changes.","volume":"100","author":"Hirst","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"R12-15-20210204","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0090-9556(25)08220-0","article-title":"Evidence for CYP3A-mediated N demethylation of amiodarone in human liver microsomal fraction.","volume":"21","author":"Fabre","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"R13-15-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1592\/phco.19.3.249.30929","article-title":"Impact of rifampin on serum amiodarone concentrations in a patient with congenital heart disease.","volume":"19","author":"Zarembski","year":"1999","journal-title":"Pharmacotherapy"},{"key":"R14-15-20210204","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9394(88)90315-7","article-title":"Amiodarone keratopathy in the donor cornea.","volume":"105","author":"Garrett","year":"1988","journal-title":"Am J Ophthalmol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003226-201201000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T12:45:39Z","timestamp":1741783539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201201000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3182107c8e","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}